SynBioBeta Speaker
Krishna Kannan
Vice President, Product Development
Telesis Bio
Krishna Kannan, Ph. D., MBA, is a biotechnology leader specializing in product development and synthetic biology. As Vice President of Product Development at Telesis Bio, he leads the commercialization of cutting-edge enzymatic DNA synthesis technologies, including the Gibson SOLA platform. With deep expertise in genome editing, DNA synthesis, and synthetic biology, Krishna has spearheaded the development of automated solutions for synthetic biology applications, enabling scalable and efficient workflows. His work includes pioneering genome synthesis efforts, launching innovative reagent kits, and driving strategic collaborations with industry leaders to advance molecular biology and automation technologies.
SynBioBeta 2025 - Session Speaker
Accelerating Biomanufacturing Through On-Demand Synthesis
This innovative approach leverages nucleic acid development from Telesis Bio and protein production from the Illinois Biological Foundry for Advanced Biomanufacturing. These thought leaders will discuss the streamlined and enhanced efficiency of producing complex biological molecules when integrating their advanced technologies, transforming the landscape of synthetic biology.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
22:21:39:28
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
2026
Event Updates